[HTML][HTML] Clinical and biological insights from viral genome sequencing

CJ Houldcroft, MA Beale, J Breuer - Nature Reviews Microbiology, 2017 - nature.com
Whole-genome sequencing (WGS) of pathogens is becoming increasingly important not
only for basic research but also for clinical science and practice. In virology, WGS is …

Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance

BG Brenner, MA Wainberg - Virus research, 2017 - Elsevier
This manuscript reviews the reasons why Integrase inhibitors should now routinely
constitute a part of first line antiretroviral therapy for the treatment of HIV disease. The use of …

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

SC Inzaule, RL Hamers, M Noguera-Julian… - The Lancet …, 2018 - thelancet.com
Background Implementation of ultrasensitive HIV drug resistance tests for routine clinical
use is hampered by uncertainty about the clinical relevance of drug-resistant minority …

The role of HIV-1 drug-resistant minority variants in treatment failure

N Stella-Ascariz, JR Arribas… - The Journal of …, 2017 - academic.oup.com
Human immunodeficiency virus type 1 (HIV-1) drug resistance genotyping is recommended
to help in the selection of antiretroviral therapy and to prevent virologic failure. There are …

Developing an appropriate evolutionary baseline model for the study of human cytomegalovirus

AA Howell, JW Terbot, V Soni, P Johri… - Genome biology and …, 2023 - academic.oup.com
Human cytomegalovirus (HCMV) represents a major threat to human health, contributing to
both birth defects in neonates as well as organ transplant failure and opportunistic infections …

Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing

T Nguyen, DB Fofana, MP Lê… - Journal of …, 2018 - academic.oup.com
Background Integrase strand transfer inhibitors (INSTIs) are recommended by international
guidelines as first-line therapy in antiretroviral-naive and-experienced HIV-1-infected …

Limited marginal utility of deep sequencing for HIV drug resistance testing in the age of integrase inhibitors

RR Dalmat, N Makhsous, GG Pepper… - Journal of Clinical …, 2018 - Am Soc Microbiol
ABSTRACT HIV drug resistance genotyping is a critical tool in the clinical management of
HIV infections. Although resistance genotyping has traditionally been conducted using …

[HTML][HTML] Validation of variant assembly using HAPHPIPE with Next-Generation sequence data from viruses

KM Gibson, MC Steiner, U Rentia, ML Bendall… - Viruses, 2020 - mdpi.com
Next-generation sequencing (NGS) offers a powerful opportunity to identify low-abundance,
intra-host viral sequence variants, yet the focus of many bioinformatic tools on consensus …

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing …

A Cozzi‐Lepri, D Dunn, A Tostevin, RL Marvig… - HIV …, 2024 - Wiley Online Library
Objectives The main objective of this analysis was to evaluate the impact of pre‐existing
drug resistance by next‐generation sequencing (NGS) on the risk of treatment failure (TF) of …

Performance comparison of deep sequencing platforms for detecting HIV‐1 variants in the pol gene

F Nicot, N Jeanne, S Raymond… - Journal of Medical …, 2018 - Wiley Online Library
The present study compares the performances of an in‐house sequencing protocol
developed on MiSeq, the Sanger method, and the 454 GS‐FLX for detecting and quantifying …